Abeona Therapeutics ABEO

$5.03 +0.02 (0.40%)

Valuation

Market cap
300,216,000
Revenue TTM
$5,820,000
Net income TTM
$71,180,000
PE ratio
0.00
Forward PE
—
Profit margin
1,223.02%
Debt to equity
0.12

Trading

Volume
1,213,400
Avg volume
1,422,154
Day's range
$4.99 – $5.11
Shares out
57,184,000
Stochastic %K
3%
Beta
1.33
Analysts
Strong Sell
Price target
$19.14

Price

Company profile

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-...

Show more

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

Industry
Biotechnology
Sector
Healthcare
Phone
646 813 4701
Website
https://www.abeonatherapeutics.com
Address
6555 Carnegie Avenue, 4th Floor, Cleveland, United States

Latest news

Stocktwits

TragicRain Oct 2, 9:37 PM
$ABEO - Happy Happy Dance!!
0 replies
Po556677 Oct 2, 6:31 PM
$ABEO The volume is funds trading back and forth with each other trying to shake shares from holders
0 replies
Dela_o_P Oct 2, 6:15 PM
$ABEO This looks like preparation for rewarding foundational employees in an acquisition. Not financial advice. Do your own DD, but this is interesting. https://finance.yahoo.com/healthcare/articles/abeona-therapeutics-announces-employee-inducement-113000310.html
1 replies
brunoq14 Oct 2, 3:44 PM
$ABEO https://www.globenewswire.com/news-release/2006/10/02/3373510/20739/en/ultragenyx-announces-marketing-authorisation-application-maa-submission-to-the-european-medicines-agency-ema-for-the-first-investigational-gene-therapy-for-mps-iiia-sanfilippo-synd.html
1 replies
Po556677 Oct 2, 2:20 PM
$ABEO Their valuing the company @ 100 million dollars (minus the cash on hand) with 2 approved drugs/Zevaskyn having a market potential of 4 billion incredibly cheap!!!!!! Someone is going buy them out on the cheap imo
0 replies
tmoney4572 Oct 2, 2:15 PM
$ABEO keep your head up boys we are fine
0 replies
HeyHoser Oct 2, 1:49 PM
$ABEO dang...
0 replies
invest2021_now Oct 2, 1:39 PM
$ABEO Added shares. Crazy that we are at $5.05! Freaking manipulation every day!
1 replies